Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Dec;16(6):722–724. doi: 10.1111/j.1365-2125.1983.tb02249.x

beta-Adrenoceptor hypersensitivity after stopping oxprenolol: discrepant findings not attributable to methodology.

H Singh, A Rimmer, M J Lewis, A H Henderson
PMCID: PMC1428344  PMID: 6318786

Abstract

Using isoprenaline and glyceryl trinitrate (GTN) induced tachycardia we have compared the rebound beta-adrenoceptor hypersensitivity on stopping slow-release and conventional oxprenolol in young normotensive subjects. Heart rate on standing with GTN rose after stopping slow-release and conventional oxprenolol to peak levels on day 2 or 3 significantly greater than corresponding control levels off treatment on day 5. The isoprenaline CD25 (the dose required to increase heart rate by 25 beats/min) fell after stopping conventional oxprenolol to a significantly lower level on day 3 than the control level off treatment on day 5. Contrary to a recent report describing no rebound beta-adrenoceptor hypersensitivity on stopping slow-release oxprenolol we have demonstrated it after stopping slow release as well as conventional oxprenolol.

Full text

PDF
722

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertel O., Bühler F. R., Kiowski W., Lütold B. E. Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension. 1980 Mar-Apr;2(2):130–138. doi: 10.1161/01.hyp.2.2.130. [DOI] [PubMed] [Google Scholar]
  2. Bolli P., Bühler F. R., Raeder E. A., Amann F. W., Meier M., Rogg H., Burckhardt D. Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol. Circulation. 1981 Dec;64(6):1130–1134. doi: 10.1161/01.cir.64.6.1130. [DOI] [PubMed] [Google Scholar]
  3. Molinoff P. B., Aarons R. D., Nies A. S., Gerber J. G., Wolfe B. B., Goens M. B. Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes. Br J Clin Pharmacol. 1982;13(Suppl 2):365S–365S. doi: 10.1111/j.1365-2125.1982.tb01942.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Rangno R. E., Langlois S. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. Br J Clin Pharmacol. 1982;13(Suppl 2):345S–351S. doi: 10.1111/j.1365-2125.1982.tb01939.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ross P. J., Lewis M. J., Sheridan D. J., Henderson A. H. Adrenergic hypersensitivity after beta-blocker withdrawal. Br Heart J. 1981 Jun;45(6):637–642. doi: 10.1136/hrt.45.6.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Szécsi E., Kohlschütter S., Schiess W., Lang E. Abrupt withdrawal of pindolol or metoprolol after chronic therapy. Br J Clin Pharmacol. 1982;13(Suppl 2):353S–357S. doi: 10.1111/j.1365-2125.1982.tb01940.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES